The insurer told the Financial Times that its remaining exposure to the failed business was not large enough to justify revising its financial guidance for the year ending in March, and that a significant portion of its Greeensill-related risk...
The insurer told the Financial Times that its remaining exposure to the failed business was not large enough to justify revising its financial guidance for the year ending in March, and that a significant portion of its Greeensill-related risk...